In the last trading session, 1.19 million Sutro Biopharma Inc (NASDAQ:STRO) shares changed hands as the company’s beta touched 1.69. With the company’s per share price at $0.91 changed hands at $0.03 or 3.77% during last session, the market valuation stood at $76.99M. STRO’s last price was a discount, traded about -468.13% off its 52-week high of $5.17. The share price had its 52-week low at $0.52, which suggests the last value was 42.86% up since then.
Analysts gave the Sutro Biopharma Inc (STRO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.36. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended STRO as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight.
Sutro Biopharma Inc (NASDAQ:STRO) trade information
Instantly STRO was in green as seen at the end of in last trading. With action 4.60%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -50.46%, with the 5-day performance at 4.60% in the green. However, in the 30-day time frame, Sutro Biopharma Inc (NASDAQ:STRO) is 68.81% up.
The consensus price target for the stock as assigned by Wall Street analysts is 2, meaning bulls need an upside of 54.5% from its current market value. According to analyst projections, STRO’s forecast low is 2 with 2 as the target high. To hit the forecast high, the stock’s price needs a -119.78% plunge from its current level, while the stock would need to soar -119.78% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -4.05%. The 2025 estimates are for Sutro Biopharma Inc earnings to increase by 35.07%, but the outlook for the next 5-year period is at 31.53% per year.
STRO Dividends
Sutro Biopharma Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.5082% or 6.91 million shares worth $20.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 2.42 shares estimated at $2.2 million under it, the former controlled 2.86% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.53% of the shares, roughly 2.13 shares worth around $1.95 million.
